Global Serum Free Media Market Insights Forecasts to 2033
- The Global Serum Free Media Market Size was Valued at USD 1.59 Billion in 2023.
- The Market Size is Growing at a CAGR of 12.9% from 2023 to 2033.
- The Worldwide Serum Free Media Market Size is Expected to Reach USD 5.39 Billion by 2033.
- Asia Pacific Market expected to grow the fastest during the forecast period.
Get more details on this report -
The Global Serum Free Media Market Size is Anticipated to Exceed USD 5.39 Billion by 2033, Growing at a CAGR of 12.9% from 2023 to 2033.
Serum-free media refer to culture media used in cell culture and bioprocessing that do not contain serum, which is traditionally derived from animal sources. Serum-free media are designed to provide all the necessary nutrients, growth factors, and other components required for the in vitro growth and maintenance of cells without the use of animal-derived serum. The growth factors and hormones for the cell functions and growth promotions were provided in serum-free media it allowing the growth of specific cell types with specific functions in cell culture kept in controlled conditions. By lowering the percentage of unequal development across cell cultures, the serum-free media eliminates potential errors and permits consistent cell growth. Many primary cultures and cell lines, such as hybridoma cell lines, Chinese hamster ovary (CHO) lines that create recombinant proteins and cell lines that serve as hosts for virus generation, are available in serum-free media formulations. Serum-free media solutions are in high demand due to growing stem cell research, biopharmaceutical production, and recombinant protein product demand. Personalized medicine is a rapidly emerging area that focuses on customizing medical treatments for specific individuals. The creation of cell-based therapies and regenerative medicine products that are utilized in personalized medicine techniques depends heavily on serum-free medium. Serum-free media are predicted to become more and more in demand as the need for personalized healthcare increases.
This research report categorizes the market for the global serum free media market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the global serum free media market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the global serum free media market.
Global Serum Free Media Market Report Coverage
|Market Size in 2023:
|USD 1.59 Billion
|Forecast Period 2023-2033 CAGR:
|2033 Value Projection:
|USD 5.39 Billion
|Historical Data for:
|No. of Pages:
|Tables, Charts & Figures:
|By Product, By Type, By Application, By End-User, By Region
|Thermo Fisher Scientific Inc., Sartorius AG, Danaher, Corning Incorporated, PAN-Biotech, Lonza Group Ltd., Merck KGaA, GE Healthcare, HiMedia Laboratories, Bio-Rad Laboratories, Inc., Sartorius AG, and Other Key Vendors.
|Pitfalls & Challenges:
|COVID-19 Empact,Challenges, Future, Growth, & Analysis
Get more details on this report -
Proteins present in cell culture media can act as substantial impurities, potentially engaging with the target component and leading to a slow purification process of the molecule. The concentration of the target protein (lead molecule) is lower in serum-free media, leading to reduced levels of impurities. Consequently, the purification of the target protein can be facilitated with increased recovery using various techniques like centrifugation, HPLC, and mass spectrometry. After generating the protein in serum-free media, it undergoes examination for precision using diverse techniques like SDS PAGE and mass spectrometry. These methods help determine whether the isolated protein is of significance. Therefore, the simplified processing of products after production in media serves as a significant factor propelling the global serum-free media market. Due to its characteristics, which include lower risk of contamination, lower risk of infectious agents, and lower possibility of components interfering, serum-free media are being utilized more frequently in the manufacturing of biopharmaceuticals, which is propelling the market's growth. The increasing number of various diseases is driving up the necessity for their treatment. This can be attributed to the biopharmaceuticals' remarkable effectiveness, which elevates their production and establishes them as the preferred therapy.
The most critical concern faced by global serum-free media market is affordability. In developed and developing countries among the well-known researchers and professionals this technology gives quick results and precise information. However, serum-free media technique is expensive as compared to other cell culture techniques. Hence, the uptake of serum-free media technology in the regions with limited resources has been hindered.
The Global Serum Free Media Market share is classified into product, type, application, and end-user
- The CHO media segment is expected to hold the largest share of the global serum free media market during the forecast period.
Based on product, the global serum free media market is divided into BHK medium, Vero medium, HEK 293 media, CHO media, stem cell medium, other serum-free media. Among these, the CHO Media segment is expected to hold the largest share of the serum free media market during the forecast period. CHO cells are well-suited for adaptation to serum-free conditions, making them a popular choice for the production of biologics. Using CHO media along with serum-free media allows for better control over the cell culture conditions. Because CHO cells can make complex proteins that resemble those found in humans, they have emerged as the gold standard in the generation of antibodies. Their remarkable tolerance for variations in temperature, pH, oxygen levels, and cell density makes them perfect for large-scale manufacturing. Their exceptional stability and adaptation to culture conditions and lack of serum, animals, and proteins can be attributed to this. As a result, CHO cell culture medium is being used by biopharmaceutical companies to produce biomedicines, increasing their global market presence.
- The liquid media segment is expected to grow at fastest pace in the global serum free media market during the forecast period.
Based on the type, the global serum free media market is divided into semi-solid & solid media and liquid media. The liquid media segment is expected to grow at fastest pace in the serum free media market during the forecast period. Liquid media types are suitable for scale-up in bioprocessing and large-scale manufacturing. Their defined composition allows for better scalability and efficient transition from small-scale research to industrial production. The utilization of liquid media is on the rise due to its advantageous features, which include eliminating the necessity for mixing containers, scales, and the installation of a Water for Injections (WFI) circuit to blend powder media.
- The biopharmaceutical production segment is expected to grow at greatest pace in the global serum free media market during the forecast period.
Based on the application, the global serum free media market is divided into biopharmaceutical production and tissue engineering & regenerative medicine. The biopharmaceutical production segment is expected to grow at greatest pace in the serum free media market during the forecast period. The increase in growth can be attributed primarily to the expected introduction of numerous monoclonal antibody (mAb) biosimilars in the upcoming years. This is a result of the expiration of patents on key medications, including trastuzumab (Herceptin by Roche), infliximab (Remicade by J&J), and Adalimumab (Humira by Abbott).
- The biopharmaceutical & pharmaceutical companies segment is expected to grow at greatest pace in the global Serum free media Market during the forecast period.
Based on the end-user, the global serum free media market is divided into research & academic institutes, biopharmaceutical & pharmaceutical companies, and others. The biopharmaceutical & pharmaceutical companies segment is expected to grow at greatest pace in the serum free media market during the forecast period. Serum-free media plays a crucial role in the bio-production process, exerting a substantial influence on the viability and growth of cells, while also improving both the quality and production of proteins. The growing number of clinical trials focusing on therapies for life-threatening diseases conducted by pharmaceutical and biotechnology firms continues to contribute to the rising demand for serum-free media.
Regional Segment Analysis of the Global Serum Free Media Market
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
- Asia-Pacific (China, Japan, India, Rest of APAC)
- South America (Brazil and the Rest of South America)
- The Middle East and Africa (UAE, South Africa, Rest of MEA)
North America is anticipated to hold the largest share of the global Serum free media market over the predicted timeframe.
Get more details on this report -
North America is anticipated to hold the largest share of the global serum free media market over the predicted timeframe. This region's future growth is influenced by a number of factors, including an established healthcare industry, refined healthcare, state-of-the-art medical infrastructure, high biopharma healthcare spending, the active presence of major industry players, and a large number of firms with a strategic pipeline for serum-free media. The dominant portion of this can be ascribed to the existence of a robust R&D infrastructure and a supportive regulatory environment that is swiftly adjusting to accommodate the continuous advancements in research within this field. There is a notable increase in investments by both the government and key market participants in the pharmaceuticals and biotechnology sectors. Because there are many biopharmaceutical companies in the region, along with research funding for cell and stem cell-based products, the existence of numerous CROs, and a well-established healthcare infrastructure, this area has a significant presence in the field.
Asia Pacific is expected to grow at the fastest pace in the global serum free media market during the forecast period. Moreover, the elevated incidence of chronic illnesses and the impact of COVID-19 have prompted heightened research and development efforts aimed at creating innovative treatments and vaccines. Therefore, there is a significant surge in the need for serum-free media solutions. The Asia-Pacific region is anticipated to create substantial revenue opportunities in the forecast period, attributed to the rising number of research and development as well as clinical trial initiatives focused on chronic and severe diseases. This potential stems from the region's expansive capacity for the development of serum-free media.
The report offers the appropriate analysis of the key organizations/companies involved within the global Serum free media along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
List of Key Companies
- Thermo Fisher Scientific Inc.
- Sartorius AG
- Corning Incorporated
- Lonza Group Ltd.
- Merck KGaA
- GE Healthcare
- HiMedia Laboratories
- Bio-Rad Laboratories, Inc.
- Sartorius AG
Key Target Audience
- Market Players
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
- In June 2022, Thermo Fisher Scientific Inc., a global leader in scientific solutions, is presenting innovative instruments, workflows, software, and collaborative partnerships aimed at empowering clients to generate fresh analytical insights and expedite the advancement of next-generation vaccines and therapies.
- In April 2021, Danaher, the initial approval of recombinant insulin and human growth hormone in the early 1980s, numerous recombinant protein therapeutics have received regulatory approval, particularly from the FDA in the United States and the EMA in Europe. With the substantial growth in the successful introduction of biological therapeutic agents, there is a critical demand in the field of drug discovery to enhance manufacturing processes for greater efficiency, necessitating highly productive cell lines. Chinese Hamster Ovary (CHO) cells, characterized as an epithelial-like cell line, have proven to be highly suitable for transfection and have established themselves as the standard for manufacturing approved therapeutic proteins.
This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the Global Serum Free Media Market based on the below-mentioned segments:
Global Serum Free Media Market, By Product
- BHK Medium
- Vero Medium
- HEK 293 Media
- CHO Media
- Stem Cell Medium
- Other Serum-free Media
Global Serum Free Media Market, By Type
- Semi-solid & Solid Media
- Liquid Media
Global Serum Free Media Market, By Application
- Biopharmaceutical Production
- Monoclonal Antibodies
- Vaccines Production
- Other Therapeutic Proteins
- Tissue Engineering & Regenerative Medicine
Global Serum Free Media Market, By End-User
- Research & Academic Institutes
- Biopharmaceutical & Pharmaceutical Companies
Global Serum Free Media Market, By Region
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- South America
- Rest of South America
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of the Middle East & Africa
Need help to buy this report?